查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1303811

血液篩查市場：按產品和服務（設備、直接購買、試劑和試劑盒）、按技術（ELISA、NAT、NGS）、按最終用戶 - 2023-2030 年全球預測

Blood Screening Market by Product & Service (Instruments, Outright Purchase, Reagents & Kits), Technology (ELISA, NAT, NGS), End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球血液篩查市場預計到 2023 年將以 8.67%的年複合成長率大幅成長，達到 49.0897 億美元，預計到 2030 年將達到驚人的 88.2691 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球血液篩查市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球血液篩查市場規模及預測是多少？

2.在預測期內，COVID-19 對全球血液篩查市場的抑制要素和影響是什麼？

3. 在預測期內，全球血液篩查市場需要投資哪些產品/細分市場/應用/領域？

4. 全球血液篩查市場的競爭策略是什麼？

5. 全球血液篩查市場的技術趨勢和法律規範是什麼？

6.全球血液篩查市場主要廠商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球血液篩查市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 捐血需求增加，捐血人數增加
      • 感染疾病的傳播和新病原體的出現
      • 血液篩查的可負擔性和核酸檢測的普及
    • 抑制因素
      • 缺乏有關血液篩查的法律、法規和政策
    • 機會
      • 血液篩查設備技術的進步
      • 改善血液篩查 POC 診斷
    • 任務
      • 血液篩查診斷費用昂貴
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 血液篩查市場（按產品和服務）

  • 設備
  • 購買
  • 試劑和試劑盒
    • ELISA 試劑和試劑盒
      • 組合
      • 控制
      • 免疫吸附劑
      • 樣品稀釋液和洗滌液
      • 基板
    • NAT 試劑和試劑盒
      • 緩衝液、核苷酸、溶液
      • 酶和聚合酶
      • 標記和檢測試劑
      • 探針和引物
      • 標準和控制

第7章 血液篩查市場：按技術分類

  • 酶聯免疫吸附法
    • 化學發光檢測法
    • 比色檢測法
    • 螢光免疫分析
  • NAT方式
    • 即時聚合酶鍊式反應
    • 轉錄媒介增幅
  • NGS
  • 快速測試
  • 蛋白質印跡分析

第8章 血液篩查市場：按最終用戶分類

  • 血庫
  • 醫院

第9章 美洲血液篩查市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太血液篩查市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲血液篩查市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-374DB5A06C00

The Global Blood Screening Market is forecasted to grow significantly, with a projected USD 4,908.97 million in 2023 at a CAGR of 8.67% and expected to reach a staggering USD 8,826.91 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Blood Screening Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Blood Screening Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Service, market is studied across Instruments, Outright Purchase, and Reagents & Kits. The Reagents & Kits is further studied across ELISA Reagents & Kits and NAT Reagents & Kits. The ELISA Reagents & Kits is further studied across Conjugates, Controls, Immunosorbents, Sample Diluents & Wash Solutions, and Substrates. The NAT Reagents & Kits is further studied across Buffers, Nucleotides, & Solutions, Enzymes & Polymerases, Labeling & Detection Reagents, Probes & Primers, and Standards & Controls. The Instruments is projected to witness significant market share during forecast period.

Based on Technology, market is studied across ELISA, NAT, NGS, Rapid Tests, and Western Blot Assays. The ELISA is further studied across Chemiluminescent Immunoassay, Colorimetric Immunoassay, and Fluorescent immunoassay. The NAT is further studied across Real-Time Polymerase Chain Reaction and Transcription-Mediated Amplification. The NAT is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Blood Banks and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Blood Screening Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Blood Screening Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Blood Screening Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Blood Screening Market?

4. What is the competitive strategic window for opportunities in the Global Blood Screening Market?

5. What are the technology trends and regulatory frameworks in the Global Blood Screening Market?

6. What is the market share of the leading vendors in the Global Blood Screening Market?

7. What modes and strategic moves are considered suitable for entering the Global Blood Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Blood Screening Market, by Product & Service, 2022 vs 2030
  • 4.3. Blood Screening Market, by Technology, 2022 vs 2030
  • 4.4. Blood Screening Market, by End-User, 2022 vs 2030
  • 4.5. Blood Screening Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for donated blood and rising number of blood donations
      • 5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
      • 5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of Legislation, Regulations, and Policies on blood screening
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in blood screening devices
      • 5.1.3.2. Improved POC diagnostics for blood screening
    • 5.1.4. Challenges
      • 5.1.4.1. High price for blood screening diagnostics
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Blood Screening Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Outright Purchase
  • 6.4. Reagents & Kits
    • 6.4.1. ELISA Reagents & Kits
      • 6.4.1.1. Conjugates
      • 6.4.1.2. Controls
      • 6.4.1.3. Immunosorbents
      • 6.4.1.4. Sample Diluents & Wash Solutions
      • 6.4.1.5. Substrates
    • 6.4.2. NAT Reagents & Kits
      • 6.4.2.1. Buffers, Nucleotides, & Solutions
      • 6.4.2.2. Enzymes & Polymerases
      • 6.4.2.3. Labeling & Detection Reagents
      • 6.4.2.4. Probes & Primers
      • 6.4.2.5. Standards & Controls

7. Blood Screening Market, by Technology

  • 7.1. Introduction
  • 7.2. ELISA
    • 7.2.1. Chemiluminescent Immunoassay
    • 7.2.2. Colorimetric Immunoassay
    • 7.2.3. Fluorescent immunoassay
  • 7.3. NAT
    • 7.3.1. Real-Time Polymerase Chain Reaction
    • 7.3.2. Transcription-Mediated Amplification
  • 7.4. NGS
  • 7.5. Rapid Tests
  • 7.6. Western Blot Assays

8. Blood Screening Market, by End-User

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals

9. Americas Blood Screening Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Blood Screening Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Blood Screening Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD SCREENING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
  • FIGURE 5. BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. BLOOD SCREENING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. BLOOD SCREENING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. BLOOD SCREENING MARKET DYNAMICS
  • FIGURE 9. BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BLOOD SCREENING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 5. BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 8. BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 10. BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 17. BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 25. BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 30. BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 147. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 155. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. VIETNAM BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. VIETNAM BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. DENMARK BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. DENMARK BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. EGYPT BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 212. EGYPT BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. FINLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. FINLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. FRANCE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 228. FRANCE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. GERMANY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 236. GERMANY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. ISRAEL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 244. ISRAEL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. ITALY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 252. ITALY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 260. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. NIGERIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 268. NIGERIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 275. NORWAY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 276. NORWAY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. POLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 284. POLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. QATAR BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 292. QATAR BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 299. RUSSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 300. RUSSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 307. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 308. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 316. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. SPAIN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 324. SPAIN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 331. SWEDEN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 332. SWEDEN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 339. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 340. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 347. TURKEY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 348. TURKEY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 349. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 350. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 355. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 356. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 357. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 358. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED